Page last updated: 2024-08-18

thiophenes and azd 6244

thiophenes has been researched along with azd 6244 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Almenara, JA; Bodie, WW; Chen, S; Dai, Y; Dent, P; Felthousen, J; Grant, S; Kramer, LB; Pei, XY; Takabatake, Y; Youssefian, LE	1
Aplin, AE; Vu, HL	1

Other Studies

2 other study(ies) available for thiophenes and azd 6244

Article	Year
Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2. Blood, 2011, Nov-10, Volume: 118, Issue:19 Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Checkpoint Kinase 1; DNA Damage; G1 Phase; Humans; Interleukin-6; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Multiple Myeloma; Protein Kinase Inhibitors; Protein Kinases; Resting Phase, Cell Cycle; Syndecan-1; Thiophenes; Urea	2011
Targeting TBK1 inhibits migration and resistance to MEK inhibitors in mutant NRAS melanoma. Molecular cancer research : MCR, 2014, Volume: 12, Issue:10 Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Gene Knockdown Techniques; GTP Phosphohydrolases; Humans; Melanoma; Membrane Proteins; Mitogen-Activated Protein Kinase Kinases; Molecular Targeted Therapy; Mutation; Neoplasm Invasiveness; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Skin Neoplasms; Thiophenes	2014

Article

Year

Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2.

Blood, 2011, Nov-10, Volume: 118, Issue:19

Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Checkpoint Kinase 1; DNA Damage; G1 Phase; Humans; Interleukin-6; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Multiple Myeloma; Protein Kinase Inhibitors; Protein Kinases; Resting Phase, Cell Cycle; Syndecan-1; Thiophenes; Urea

2011

Targeting TBK1 inhibits migration and resistance to MEK inhibitors in mutant NRAS melanoma.

Molecular cancer research : MCR, 2014, Volume: 12, Issue:10

Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Gene Knockdown Techniques; GTP Phosphohydrolases; Humans; Melanoma; Membrane Proteins; Mitogen-Activated Protein Kinase Kinases; Molecular Targeted Therapy; Mutation; Neoplasm Invasiveness; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Skin Neoplasms; Thiophenes

2014